Pathway Capital Management, LP Rubius Therapeutics, Inc. Transaction History

Pathway Capital Management, LP

  • $29.4 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$17.6 - $25.91 $1.3 Million - $1.91 Million
-73,667 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$22.26 - $28.43 $1.45 Million - $1.85 Million
65,105 Added 760.39%
73,667 $1.8 Million
Q1 2021

May 13, 2021
BUY
$8.02 - $32.01 $68,667 - $274,069
8,562 New
8,562 $227,000

Others Institutions Holding RUBY

# of Institutions
2
Shares Held
325
Call Options Held
0
Put Options Held
0
View Full List

About Rubius Therapeutics, Inc.

RUBY Quotes by TradingView
  • Ticker RUBY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 90,357,000
  • Description
  • Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...
More about RUBY
Track This Portfolio

Track Pathway Capital Management, LP Portfolio

Follow Pathway Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathway Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pathway Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email